There was a severe reversal in fortunes this week as the
OPTI:Optibiotix optimism hit a bit of a wall and the price fell,
followed soon after by SBTX:SkinBioTherapeutics when a 4.5m share sale
went through at the end of the day. The result was a drop in portfolio value
of £5,725 and half last week's gains gone. The deficit between cost and value
went up to £28,812 and total portfolio value is now £86,105.
Biggest loser was SBTX:SkinBioTherapeutics which crashed 17% in my SIPP
and 13% in my ISA. I'm so frustrated that I didn't sell the lot at 20p when
the order was in but I just couldn't get it dealt before the price fell. I
would have been able to significantly increase my holding now they are 14p. It
looks like the reason for the drop is a thumping great 4.5 million share sale.
That would be exactly what OPTI:Optibiotix need to dispose of to get
below 30% and no longer have to report SBTX losses in the accounts, and
to enable a Nasdaq listing. I'm still miffed, but there's a good chance they
will head back up from here.
OPTI:Optibiotix fell 5p which is 8% and made up most of my losses
this week. I still haven't had a chance to report them being in profit, but
they were looking good on Tuesday. The results were a disappointment, mainly
because some of the revenue quoted in the trading update couldn't be accounted
for in this year due to new reporting regulations, and costs were higher than
I expected. I was expecting a £1.5m loss but it was a £2m loss. It's taking a
lot longer than expected to get to break-even. This is still looking bright
for the future though.
IES:Invinity Energy had another good week, climbing 6%. They are now
only down 82%, which given I thought they would go bust a few weeks ago gives
me a glimmer of hope.
Share of the Week picked a really bad time to put in s stellar performance,
seeing as I wanted to buy some. CAML:Central Asia Metals climbed 7% and
that cost me dear when my pension transfer finally appeared. I am very, very
happy to say that I have increased my holding to 5,000 shares and am now
waiting for news that the dividend will be re-instated, as it's going to be
£400 with my enlarged holding.
Not what I wanted to see - especially as there was a big hike in the cash
injection.
This shows the size of the drop more accurately, as it's not been flattened by
the cash injection. Last time we had 2 weeks of drops before the up-turn.
Hopefully that won't happen again this time.
Here's the performance of the ISA and share accounts:
| Weekly Change | |||
| Cash | £7.98 | +£0 | |
| Portfolio cost | £59,827.79 | +£0 | |
| Portfolio sell value (bid price-commission) | £43,272.85 | (-27.7%) | -£3.281.91 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.63 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£20.20 | (-0.4%) | +£0.48 |
| Total Dividends | £1,342.93 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £368.45 | (7.4%) | -£1.47 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Performance/Injection | 11.2% | -0.1% | |
| Compound performance | 54% | +0% |
Very quiet and all the drop down to SBTX:SkinBioTherapeutics and
OPTI:Optibiotix.
Big drop, very bad.
Still flattening the line, but slowly.
The SIPP looks like this after week 235
| Weekly Change | ||||
| Cash | £656.78 | +£626.77 | ||
| Portfolio cost | £51,935.21 | +£2,266.55 | ||
|
Portfolio sell value (bid price - commission) |
£40,574.40 | (-21.9%) | -£2,458.70 | |
| Potential profits | £0 | -£239.14 | ||
| Yr 5 Dividends | £0 | +£0 | ||
| Yr 5 Interest | £0.03 | +£0 | ||
| Yr 5 Profit from sales | £0 | +£0 | ||
| Yr 5 Average monthly cash profit | -£13.10 | (-0.3%) | +£0.50 | |
| Total Dividends | £1,899.24 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £12,549.10 | +£0 | ||
| Average monthly cash profit | £256.75 | (5.9%) | -£1.09 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Performance/Injection | 8.9% | -0.8% | ||
| Compound performance | 40% | -4% |
Lots more happening here. First of all my transfer of £2,800 came through on
Friday afternoon, so I immediately purchased
CAML:Central Asia Metals to achieve my ambition of having 5,000 shares.
I bought 747 shares at 153.372p costing £1,157.64. I'm frustrated that when
the transfer should have happened these were 132p, so it has cost me £159 more
to buy the shares than it should have done, and I've lost out on a 16% gain
which would have had knock-on benefits to the size of my dividend. However, I
did reduce my average holding price to 186p so they were still a bargain.
I also instigated my magic formula experiment with 562 shares in
FXPO:Ferrexpo at 177.695p costing £1,015.59 with commission and stamp
duty. I know I have a real share when I have to pay stamp duty! These were
140p when I should have had the transfer, so rather than costing more money (I
fix it at £1,000 of shares), I could have bought 714 shares instead of 562,
which would have been an extra 152 shares. That's also very annoying, but I
still consider these to be very cheap. I've just got to hope their ex-CEO
doesn't dump all his shares to pay a big fine, and hope the Ukrainian
government don't confiscate the mine for his crimes. I think that's why the
shares are so cheap, so I just need to hope.
That leaves me with £656 cash, which was meant to be added to the £500 tax
rebate to buy my second magic formula share. Unfortunately I spent that one
one of my amazing short term can't fail companies which has since dropped, so
I'm stuck waiting until I can get the money back. It's not the end of the
world as I need to completely re-do my spreadsheet to find which company is
now number 2 on the list. The alternative would be to stick £356 in the
account and keep JLP:Jubilee Metals for a while. Given the amount I'm
saving during lock-down, that may be a nice option.
Potential profits vanished as SBTX:SkinBioTherapeutics crashed thanks
to the 4.5 million share sale. Performance has also tanked due to the increase
in cost and injection amount. Even compound performance lost 4% because of the
increase in capital invested.
Big hike in cost and injection, but much smaller hike in value. At least the
drop in value was less than the injection so it didn't drop.
That's a more realistic chart, but I'm fairly relaxed about it.
Here's the trading account after week 201
| Weekly Change | |||
| Cash | £0.09 | +£0 | |
| Portfolio cost | £2,490.21 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,593.72 | (-36.0%) | +£15.18 |
| Potential profits | £65.01 | -£22.63 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £120.77 | +£0 | |
| Yr 4 Average monthly cash profit | £12.90 | (6.2%) | -£0.29 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | £56.48 | +£0 | |
| Average monthly cash profit | £2.25 | (1.1%) | -£0.01 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Performance/Injection | 1.2% | +0% | |
| Compound performance | 5% | +0% |
Sell value improved largely thanks to CAML:Central Asia Metals, and
JLP:Jubilee Metals dropped, rather drastically reducing the potential
profit. I now have two accounts with a short term
JLP:Jubilee Metals holding I want to get rid of.
Creeping higher...
I do believe there's a risk this line may flatten!
The virtual magic formula pension is now down 15.2% compared to 18.36% last
week, so getting better. PLUS:Plus 500 is still the top performer,
but FXPO:Ferrexpo is now 2nd at 19.36% improvement. I could shudder
with incandescent rage! It will be interesting to see which company comes 2nd
on the list. It was PLUS:Plus 500 when I first started this, but with
the price rise they should be well down the list now. I'm hoping it's not
CARD:Card Factory as they are 59% down and that might put them in
bargain territory. However, will they survive the lock-down?
I'm not writing any more today, as the sun is glaring through the window and I
need a pot of tea and a comfy chair.
No comments:
Post a Comment